Get the Daily Brief
Latest Biotech News
Trump administration demands pharma start drug price talks
The Trump administration is pressing pharmaceutical companies to begin negotiations aimed at aligning U.S. drug prices with those of comparable economies, which are generally lower. The Department...
AI neuroprosthesis restores expressive speech for ALS patient
Researchers have demonstrated a brain-computer interface that decodes neural signals to generate synthesized speech with paralinguistic features such as tone and melody in real time. Implanted...
BioNTech acquires CureVac to end mRNA patent battle
BioNTech announced a $1.25 billion all-stock acquisition of German biotech CureVac, resolving ongoing messenger RNA patent disputes. CureVac's shareholders will receive BioNTech shares valued at a...
Rice University improves CO₂-to-fuel conversion stability
A Rice University team developed a method using acid-humidified CO₂ to prevent salt accumulation that disrupts gas flow in electrochemical systems converting carbon dioxide into fuels. This...
New soft bioelectronics enable embryonic brain activity mapping
Harvard bioengineers designed ultrathin, flexible mesh microelectrode arrays that integrate seamlessly into the developing neural plate of tadpole embryos. This innovative implant expands...
NK cell sensitivity boost offers new cancer immunotherapy avenue
Researchers at Monash University and oNKo-Innate identified a gene whose inhibition in natural killer (NK) cells amplifies their sensitivity to IL-15, an immune growth factor imperative for cancer...
Med-tech firm Agilent launches advanced LC-MS systems
Agilent Technologies introduced the InfinityLab Pro iQ Series, a new generation of liquid chromatography-mass spectrometry platforms designed for pharmaceutical, biopharmaceutical, and...
Glycosaminoglycan-driven lipoprotein uptake shields tumors
A study revealed that cancer cells utilize sulfated glycosaminoglycans on their surface to mediate uptake of lipoproteins carrying α-tocopherol, a form of vitamin E that inhibits ferroptosis, an...
BioNTech buys mRNA rival CureVac in $1.25 billion all-stock deal
BioNTech agreed to acquire CureVac for $1.25 billion in an all-stock transaction resolving pending patent litigation and enhancing BioNTech’s manufacturing and oncology pipeline. The deal...
Nuvation Bio gets FDA nod for Ibtrozi in ROS1 lung cancer fight
Nuvation Bio’s FDA approval of Ibtrozi, a next-generation tyrosine kinase inhibitor for ROS1-positive non-small cell lung cancer, demonstrates clinical efficacy with favorable safety, offering a...
Genentech lays off 143 workers at South San Francisco campus
Genentech announced layoffs impacting 143 employees at its South San Francisco headquarters amid operational realignment and cost optimization efforts. The workforce reduction follows previous...
BioNTech Expands Oncology Reach with CureVac Acquisition
BioNTech is acquiring CureVac in a $1.25 billion all-stock deal, resolving ongoing mRNA patent litigation and gaining CureVac’s advanced manufacturing capabilities. This strategic purchase...
FDA Clears Nuvation's Lung Cancer Drug to Challenge Industry Giants
The FDA approved Nuvation Bio’s Ibtrozi for treating ROS1-positive non-small cell lung cancer, marking the company's entry into a competitive market dominated by Pfizer, Bristol Myers Squibb, and...
Merck Enters Pediatric RSV Market with New Monoclonal Antibody
Merck received FDA approval for Enflonsia (cesrovimab), a long-acting monoclonal antibody preventing RSV lower respiratory tract disease in infants, joining existing pediatric RSV antibody...
GSK Advances Multiple Myeloma Therapy with Blenrep Data
GSK presented updated clinical trial data for Blenrep combined with Pomalyst and dexamethasone demonstrating prolonged progression-free survival in relapsed or refractory multiple myeloma...
Novel Brain-Computer Interface Enables Real-Time Speech with Natural Voice
Researchers successfully demonstrated a brain-to-voice neuroprosthesis that synthesizes speech instantaneously from neural signals in a man with ALS, capturing prosodic features such as tone and...
AI-Powered Advances Transform Cardiometabolic Drug Discovery
Deep Apple Therapeutics and Novo Nordisk entered a collaboration valued up to $812 million to develop small molecule therapies targeting non-incretin GPCRs for cardiometabolic diseases, including...
Big Data Initiatives and Biotech Expansion Drive Innovation Momentum
Basecamp Research unveiled BaseData, a 9.8-billion protein sequence database encompassing one million novel species, addressing critical data shortages hindering AI-driven biological discovery....
Synthetic Biology Boosts Antibody Production Sustainability
Enduro Genetics presented synthetic biology innovations enabling enhanced monoclonal antibody production by engineering cellular pathways to counteract micro-evolution-induced productivity loss in...
Novel Precision Antibiotic Activated by Green Light Targets Resistance
A team engineered a green-light-activatable form of penicillin, enabling spatial and temporal control of antibiotic activity to precisely target infections while reducing systemic exposure and...